New Product Launch

New Product Launch: Norepinephrine

Juno Pharmaceuticals Canada is pleased to announce the launch of our latest product, Norepinephrine Bitrate for injection which is available at your local Canadian wholesalers!


Norepinephrine is indicated for the restoration and maintenance of blood pressure in acute hypotensive or shock states ,such as surgery, trauma, hemorrhage myocardial infarction, pheochromocytomectomy, sympathectomy, spinal anesthesia, septicemia, drug reactions, poliomyelitis and blood transfusion reactions.
 

.

By Dewan Tasinuzzaman August 29, 2024
Juno - CPHI 2024
By Dewan Tasinuzzaman August 21, 2024
New Product Launch: Eptifibatide
By Dewan Tasinuzzaman January 11, 2024
Quality & Compliance Specialist
By Dewan Tasinuzzaman October 19, 2023
Regulatory Affairs Project Manager 
By Dewan Tasinuzzaman September 11, 2023
Quality & Compliance Associate
By Dewan Tasinuzzaman May 15, 2023
Juno Pharmaceuticals est fier d'être partenaire avec Omega Laboratories
By Dewan Tasinuzzaman May 15, 2023
Juno Pharmaceuticals is proud to acquire Omega Laboratories
By Dewan Tasinuzzaman April 24, 2023
Juno Pharmaceuticals Canada & Rosemont Joint Partnership Announcement
By Dewan Tasinuzzaman April 6, 2023
New Product Launch: Bortezomib
By Dewan Tasinuzzaman April 6, 2023
Juno Pharmaceuticals Canada & J. Molner Joint Partnership Announcement
More Posts